Engineered class 2, type v repressor systems
AssigneeScribe Therapeutics Inc.
InventorsJason FERNANDES, Ross WHITE, Sean HIGGINS, Sarah DENNY, Benjamin OAKES, Emeric Jean Marius CHARLES
Life of this patent
Estimating the term…
Abstract
The disclosure relates to gene repressor systems comprising catalytically-dead Class 2 CRISPR proteins and one or more transcription repressor domains linked to the catalytically-dead Class 2 CRISPR protein as a fusion protein, as well as a guide ribonucleic acid (gRNA); and methods of making and using same.
Claims30
A gene repressor system comprising:
- a. an RNA encoding a fusion protein, the fusion protein comprising:
- i. a catalytically-dead Class 2, Type V CRISPR protein;
- ii. a first transcription repressor domain comprising a sequence at least 70% identical to SEQ ID NO:
- 57755;
- iii. a second transcription repressor domain;
- and
- iv. a third transcription repressor domain, and
- b. a guide ribonucleic acid (gRNA) capable of forming ribonucleoprotein (RNP) with the fusion protein, wherein the gRNA comprises a targeting sequence complementary to a target nucleic acid sequence of a gene targeted for repression, silencing, or downregulation.
A method of repressing transcription of a target nucleic acid sequence in a cell, comprising introducing into the cell a gene repressor system comprising:
- a. an RNA encoding a fusion protein, the fusion protein comprising:
- i. a catalytically-dead Class 2, Type V CRISPR protein;
- ii. a first transcription repressor domain comprising a sequence at least 70% identical to SEQ ID NO:
- 57755;
- iii. a second transcription repressor domain;
- and
- iv. a third transcription repressor domain, and
- b. a guide ribonucleic acid (gRNA) capable of forming ribonucleoprotein (RNP) with the fusion protein, wherein the gRNA comprises a targeting sequence complementary to a target nucleic acid sequence of a gene targeted for repression, silencing, or downregulation.
A gene repressor system comprising:
- a. an RNA encoding a fusion protein, the fusion protein comprising:
- i. a catalytically-dead Class 2, Type V CRISPR protein;
- ii. a first transcription repressor domain comprising a sequence at least 70% identical to SEQ ID NO:
- 57771 or SEQ ID NO:
- 57779;
- iii. a second transcription repressor domain;
- and
- iv. a third transcription repressor domain, and
- b. a guide ribonucleic acid (gRNA) capable of forming ribonucleoprotein (RNP) with the fusion protein, wherein the gRNA comprises a targeting sequence complementary to a target nucleic acid sequence of a gene targeted for repression, silencing, or downregulation.
A method of repressing transcription of a target nucleic acid sequence in a cell, comprising introducing into the cell a gene repressor system comprising:
- a. an RNA encoding a fusion protein, the fusion protein comprising:
- i. a catalytically-dead Class 2, Type V CRISPR protein;
- ii. a first transcription repressor domain comprising a sequence at least 70% identical to SEQ ID NO:
- 57771 or SEQ ID NO:
- 57779;
- iii. a second transcription repressor domain;
- and
- iv. a third transcription repressor domain, and
- b. a guide ribonucleic acid (gRNA) capable of forming ribonucleoprotein (RNP) with the fusion protein, wherein the gRNA comprises a targeting sequence complementary to a target nucleic acid sequence of a gene targeted for repression, silencing, or downregulation.
Dependencies are inferred from the claim text.